Edwards Lifesciences Revenue 2011-2025 | EW
Edwards Lifesciences annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Edwards Lifesciences revenue for the quarter ending September 30, 2025 was $1.553B, a 14.67% increase year-over-year.
- Edwards Lifesciences revenue for the twelve months ending September 30, 2025 was $5.884B, a 16.16% increase year-over-year.
- Edwards Lifesciences annual revenue for 2024 was $5.44B, a 8.57% increase from 2023.
- Edwards Lifesciences annual revenue for 2023 was $5.01B, a 12.23% increase from 2022.
- Edwards Lifesciences annual revenue for 2022 was $4.464B, a 14.69% decline from 2021.
|
Edwards Lifesciences Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $5,440 |
| 2023 | $5,010 |
| 2022 | $4,464 |
| 2021 | $5,233 |
| 2020 | $4,386 |
| 2019 | $4,348 |
| 2018 | $3,723 |
| 2017 | $3,435 |
| 2016 | $2,964 |
| 2015 | $2,494 |
| 2014 | $2,323 |
| 2013 | $2,046 |
| 2012 | $1,900 |
| 2011 | $1,679 |
| 2010 | $1,447 |
|
Edwards Lifesciences Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $1,553 |
| 2025-06-30 | $1,532 |
| 2025-03-31 | $1,413 |
| 2024-12-31 | $1,386 |
| 2024-09-30 | $1,354 |
| 2024-06-30 | $1,369 |
| 2024-03-31 | $1,330 |
| 2023-12-31 | $1,012 |
| 2023-09-30 | $1,243 |
| 2023-06-30 | $1,296 |
| 2023-03-31 | $1,460 |
| 2022-12-31 | $430 |
| 2022-09-30 | $1,319 |
| 2022-06-30 | $1,374 |
| 2022-03-31 | $1,341 |
| 2021-12-31 | $1,330 |
| 2021-09-30 | $1,310 |
| 2021-06-30 | $1,376 |
| 2021-03-31 | $1,217 |
| 2020-12-31 | $1,192 |
| 2020-09-30 | $1,141 |
| 2020-06-30 | $925 |
| 2020-03-31 | $1,129 |
| 2019-12-31 | $1,174 |
| 2019-09-30 | $1,094 |
| 2019-06-30 | $1,087 |
| 2019-03-31 | $993 |
| 2018-12-31 | $978 |
| 2018-09-30 | $907 |
| 2018-06-30 | $944 |
| 2018-03-31 | $895 |
| 2017-12-31 | $889 |
| 2017-09-30 | $822 |
| 2017-06-30 | $842 |
| 2017-03-31 | $884 |
| 2016-12-31 | $768 |
| 2016-09-30 | $739 |
| 2016-06-30 | $759 |
| 2016-03-31 | $697 |
| 2015-12-31 | $671 |
| 2015-09-30 | $616 |
| 2015-06-30 | $617 |
| 2015-03-31 | $590 |
| 2014-12-31 | $618 |
| 2014-09-30 | $607 |
| 2014-06-30 | $575 |
| 2014-03-31 | $522 |
| 2013-12-31 | $536 |
| 2013-09-30 | $496 |
| 2013-06-30 | $517 |
| 2013-03-31 | $497 |
| 2012-12-31 | $511 |
| 2012-09-30 | $448 |
| 2012-06-30 | $482 |
| 2012-03-31 | $459 |
| 2011-12-31 | $430 |
| 2011-09-30 | $413 |
| 2011-06-30 | $431 |
| 2011-03-31 | $405 |
| 2010-12-31 | $392 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $49.418B | $5.440B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.349B | 26.18 |
| Intuitive Surgical (ISRG) | United States | $205.110B | 80.25 |
| IDEXX Laboratories (IDXX) | United States | $56.892B | 56.50 |
| Alcon (ALC) | Switzerland | $38.157B | 25.79 |
| IQVIA Holdings (IQV) | United States | $37.216B | 20.75 |
| Mettler-Toledo (MTD) | United States | $29.520B | 34.54 |
| STERIS (STE) | Ireland | $26.176B | 27.02 |
| Waters (WAT) | United States | $22.989B | 30.41 |
| DexCom (DXCM) | United States | $22.672B | 31.25 |
| Hologic (HOLX) | United States | $16.592B | 17.47 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.147B | 0.00 |
| Globus Medical (GMED) | United States | $11.472B | 23.86 |
| Penumbra (PEN) | United States | $10.953B | 77.05 |
| Masimo (MASI) | United States | $7.879B | 25.25 |
| Sysmex ADR (SSMXY) | Japan | $6.616B | 21.02 |
| Glaukos (GKOS) | United States | $5.163B | 0.00 |
| Teleflex (TFX) | United States | $4.961B | 7.91 |
| TransMedics (TMDX) | United States | $4.174B | 49.45 |
| Veracyte (VCYT) | United States | $3.372B | 38.43 |
| Alphatec Holdings (ATEC) | United States | $3.078B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.877B | 15.54 |
| Integer Holdings (ITGR) | United States | $2.446B | 11.48 |
| Artivion (AORT) | United States | $2.220B | 101.87 |
| Nihon Kohden (NHNKY) | Japan | $1.815B | 15.84 |
| PROCEPT BioRobotics (PRCT) | United States | $1.751B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| Beta Bionics (BBNX) | United States | $1.269B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.188B | 0.00 |
| AxoGen (AXGN) | United States | $1.128B | 0.00 |
| IRadimed (IRMD) | United States | $1.077B | 51.30 |
| Pulse Biosciences (PLSE) | United States | $1.038B | 0.00 |
| OPKO Health (OPK) | United States | $1.021B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.960B | 5.20 |
| SiBone (SIBN) | United States | $0.791B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.607B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.562B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.561B | 32.60 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.541B | 10.80 |
| AngioDynamics (ANGO) | United States | $0.520B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.495B | 0.00 |
| NeuroPace (NPCE) | United States | $0.449B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.442B | 12.20 |
| OrthoPediatrics (KIDS) | United States | $0.432B | 0.00 |
| RxSight (RXST) | United States | $0.421B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.414B | 3.25 |
| Sight Sciences (SGHT) | United States | $0.372B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.334B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.312B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.304B | 50.71 |
| CVRx (CVRX) | United States | $0.258B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.214B | 0.00 |
| 908 Devices (MASS) | United States | $0.213B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.166B | 0.00 |
| Neuronetics (STIM) | United States | $0.151B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.139B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.125B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.092B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.053B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.044B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.53 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |